Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Dupuytren's Disease”

6 trials

Showing 6 of 6 results

Not applicableStudy completedNCT00954746
What this trial is testing

Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859

Who this might be right for
Dupuytren's Disease
Endo USA Inc., a Keenova Therapeutics Company 645
Testing effectiveness (Phase 2)Looking for participantsNCT06321991
What this trial is testing

Nodular Shrinking in Dupuytren Disease

Who this might be right for
Dupuytren's Disease
Universitaire Ziekenhuizen KU Leuven 80
Large-scale testing (Phase 3)Study completedNCT00528840
What this trial is testing

Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease

Who this might be right for
Advanced Dupuytren's Disease
Endo USA Inc., a Keenova Therapeutics Company 201
Large-scale testing (Phase 3)Study completedNCT00528424
What this trial is testing

AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease

Who this might be right for
Advanced Dupuytren's Disease
Endo USA Inc., a Keenova Therapeutics Company 286
Not applicableStudy completedNCT07505563
What this trial is testing

MiniFlo for Advanced Dupuytren's Disease

Who this might be right for
Dupuytren's Disease
Azienda Ospedaliera Universitaria Integrata Verona 18
Large-scale testing (Phase 3)Study completedNCT00533273
What this trial is testing

Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease

Who this might be right for
Advanced Dupuytren's Disease
Endo USA Inc., a Keenova Therapeutics Company 66

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation